Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer

IntroductionETAA1 is recruited to DNA damage sites via its RPA -binding and ATR -activating domain (AAD) motifs, where RPA binding is crucial for ETAA1’s regulation of ATR activity. Methods & resultsOur findings associate Programmed Death- Ligand1 (PD-L1) with the RPA1-ETAA1 axis, suggesting...

Full description

Saved in:
Bibliographic Details
Main Authors: Gaofeng Qin, Zengkuan Chen, Weihong Tian, Hongbo Chen, Yu Zhang, Wangzhi Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1492531/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850160460487196672
author Gaofeng Qin
Gaofeng Qin
Zengkuan Chen
Zengkuan Chen
Weihong Tian
Hongbo Chen
Yu Zhang
Yu Zhang
Wangzhi Wei
Wangzhi Wei
author_facet Gaofeng Qin
Gaofeng Qin
Zengkuan Chen
Zengkuan Chen
Weihong Tian
Hongbo Chen
Yu Zhang
Yu Zhang
Wangzhi Wei
Wangzhi Wei
author_sort Gaofeng Qin
collection DOAJ
description IntroductionETAA1 is recruited to DNA damage sites via its RPA -binding and ATR -activating domain (AAD) motifs, where RPA binding is crucial for ETAA1’s regulation of ATR activity. Methods & resultsOur findings associate Programmed Death- Ligand1 (PD-L1) with the RPA1-ETAA1 axis, suggesting that upregulated RPA1 -dependent ETAA1 may facilitate PD-L1 nuclear accumulation. We observed strong correlations between ETAA1 and RPA1 with the components involved in HDAC2-mediated deacetylation, clathrin -dependent endocytosis, and PD-L1 nucleocytoplasmic shuttling, aligning with the established regulatory pathway of PD-L1 nuclear translocation. Moreover, nuclear PD-L1 transactivates a panel of pro-inflammatory and immune response transcription factors, potentially reshaping the tumor immune microenvironment. We identified a landscape of infiltrating lymphocytes influenced by ETAA1, finding that levels of ETAA1 were negatively correlated with CD8+ T and Natural Killer T (NKT) cells, but positively correlated with CD4+ T helper 2 (Th2) cells, cancer-associated fibroblasts (CAFs), myeloid-derived suppressor cells (MDSCs), neutrophils and regulatory T cells (Tregs), suggesting a potential role in immune evasion. Further analysis shows that the RPA1-ETAA1 axis is significantly associated with multiple metastasis mediators and unfavorable liver cancer progression, with higher expression observed in advanced stages and poorly differentiated subgroups. Discussion & conclusionThese findings expand the role of the RPA1-ETAA1 axis beyond DNA repair, highlighting its potential as a target for cancer therapy.
format Article
id doaj-art-ff0bf2aef5d24c68a91d99b114d92ea9
institution OA Journals
issn 1664-3224
language English
publishDate 2024-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-ff0bf2aef5d24c68a91d99b114d92ea92025-08-20T02:23:08ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-11-011510.3389/fimmu.2024.14925311492531Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancerGaofeng Qin0Gaofeng Qin1Zengkuan Chen2Zengkuan Chen3Weihong Tian4Hongbo Chen5Yu Zhang6Yu Zhang7Wangzhi Wei8Wangzhi Wei9Liaoning Technology and Engineering Center for Tumor Immunology and Molecular Theranotics, Collaborative Innovation Center for Age-related Disease, Life Science Institute, Jinzhou Medical University, Jinzhou, Liaoning, ChinaCollege of Basic Medical Science, Jinzhou Medical University, Jinzhou, Liaoning, ChinaLiaoning Technology and Engineering Center for Tumor Immunology and Molecular Theranotics, Collaborative Innovation Center for Age-related Disease, Life Science Institute, Jinzhou Medical University, Jinzhou, Liaoning, ChinaCollege of Basic Medical Science, Jinzhou Medical University, Jinzhou, Liaoning, ChinaLiaoning Technology and Engineering Center for Tumor Immunology and Molecular Theranotics, Collaborative Innovation Center for Age-related Disease, Life Science Institute, Jinzhou Medical University, Jinzhou, Liaoning, ChinaDepartment of Intensive Care Medicine, Yingkou Central Hospital, Yingkou, Liaoning, ChinaLiaoning Technology and Engineering Center for Tumor Immunology and Molecular Theranotics, Collaborative Innovation Center for Age-related Disease, Life Science Institute, Jinzhou Medical University, Jinzhou, Liaoning, ChinaCollege of Basic Medical Science, Jinzhou Medical University, Jinzhou, Liaoning, ChinaLiaoning Technology and Engineering Center for Tumor Immunology and Molecular Theranotics, Collaborative Innovation Center for Age-related Disease, Life Science Institute, Jinzhou Medical University, Jinzhou, Liaoning, ChinaCollege of Basic Medical Science, Jinzhou Medical University, Jinzhou, Liaoning, ChinaIntroductionETAA1 is recruited to DNA damage sites via its RPA -binding and ATR -activating domain (AAD) motifs, where RPA binding is crucial for ETAA1’s regulation of ATR activity. Methods & resultsOur findings associate Programmed Death- Ligand1 (PD-L1) with the RPA1-ETAA1 axis, suggesting that upregulated RPA1 -dependent ETAA1 may facilitate PD-L1 nuclear accumulation. We observed strong correlations between ETAA1 and RPA1 with the components involved in HDAC2-mediated deacetylation, clathrin -dependent endocytosis, and PD-L1 nucleocytoplasmic shuttling, aligning with the established regulatory pathway of PD-L1 nuclear translocation. Moreover, nuclear PD-L1 transactivates a panel of pro-inflammatory and immune response transcription factors, potentially reshaping the tumor immune microenvironment. We identified a landscape of infiltrating lymphocytes influenced by ETAA1, finding that levels of ETAA1 were negatively correlated with CD8+ T and Natural Killer T (NKT) cells, but positively correlated with CD4+ T helper 2 (Th2) cells, cancer-associated fibroblasts (CAFs), myeloid-derived suppressor cells (MDSCs), neutrophils and regulatory T cells (Tregs), suggesting a potential role in immune evasion. Further analysis shows that the RPA1-ETAA1 axis is significantly associated with multiple metastasis mediators and unfavorable liver cancer progression, with higher expression observed in advanced stages and poorly differentiated subgroups. Discussion & conclusionThese findings expand the role of the RPA1-ETAA1 axis beyond DNA repair, highlighting its potential as a target for cancer therapy.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1492531/fullreplication protein A (RPA)Ewing tumor-associated antigen 1 (ETAA1)PD-L1immune infiltrationliver cancer
spellingShingle Gaofeng Qin
Gaofeng Qin
Zengkuan Chen
Zengkuan Chen
Weihong Tian
Hongbo Chen
Yu Zhang
Yu Zhang
Wangzhi Wei
Wangzhi Wei
Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer
Frontiers in Immunology
replication protein A (RPA)
Ewing tumor-associated antigen 1 (ETAA1)
PD-L1
immune infiltration
liver cancer
title Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer
title_full Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer
title_fullStr Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer
title_full_unstemmed Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer
title_short Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer
title_sort exploring rpa1 etaa1 axis via high throughput data analysis implications for pd l1 nuclear translocation and tumor immune dynamics in liver cancer
topic replication protein A (RPA)
Ewing tumor-associated antigen 1 (ETAA1)
PD-L1
immune infiltration
liver cancer
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1492531/full
work_keys_str_mv AT gaofengqin exploringrpa1etaa1axisviahighthroughputdataanalysisimplicationsforpdl1nucleartranslocationandtumorimmunedynamicsinlivercancer
AT gaofengqin exploringrpa1etaa1axisviahighthroughputdataanalysisimplicationsforpdl1nucleartranslocationandtumorimmunedynamicsinlivercancer
AT zengkuanchen exploringrpa1etaa1axisviahighthroughputdataanalysisimplicationsforpdl1nucleartranslocationandtumorimmunedynamicsinlivercancer
AT zengkuanchen exploringrpa1etaa1axisviahighthroughputdataanalysisimplicationsforpdl1nucleartranslocationandtumorimmunedynamicsinlivercancer
AT weihongtian exploringrpa1etaa1axisviahighthroughputdataanalysisimplicationsforpdl1nucleartranslocationandtumorimmunedynamicsinlivercancer
AT hongbochen exploringrpa1etaa1axisviahighthroughputdataanalysisimplicationsforpdl1nucleartranslocationandtumorimmunedynamicsinlivercancer
AT yuzhang exploringrpa1etaa1axisviahighthroughputdataanalysisimplicationsforpdl1nucleartranslocationandtumorimmunedynamicsinlivercancer
AT yuzhang exploringrpa1etaa1axisviahighthroughputdataanalysisimplicationsforpdl1nucleartranslocationandtumorimmunedynamicsinlivercancer
AT wangzhiwei exploringrpa1etaa1axisviahighthroughputdataanalysisimplicationsforpdl1nucleartranslocationandtumorimmunedynamicsinlivercancer
AT wangzhiwei exploringrpa1etaa1axisviahighthroughputdataanalysisimplicationsforpdl1nucleartranslocationandtumorimmunedynamicsinlivercancer